Drug Manufacturers Stock News
Categories
- All
- Editor's Picks
- Q&A with Gurus
- Gurus' Stock Picks
- Insider Transaction
- Earning Reports
- CEO Shareholder Letters
- Press Release
- Earnings Call Transcripts
- Podcast
Industries
- Aerospace & Defense
- Agriculture
- Asset Management
- Banks
- Beverages - Alcoholic
- Beverages - Non-Alcoholic
- Biotechnology
- Building Materials
- Business Services
- Capital Markets
- Chemicals
- Conglomerates
- Construction
- Consumer Packaged Goods
- Credit Services
- Diversified Financial Services
- Drug Manufacturers
- Education
- Farm & Heavy Construction Machinery
- Forest Products
- Furnishings, Fixtures & Appliances
- Hardware
- Healthcare Plans
- Healthcare Providers & Services
- Homebuilding & Construction
- Industrial Distribution
- Industrial Products
- Insurance
- Interactive Media
- Manufacturing - Apparel & Accessories
- Media - Diversified
- Medical Devices & Instruments
- Medical Diagnostics & Research
- Medical Distribution
- Metals & Mining
- Oil & Gas
- Other Energy Sources
- Packaging & Containers
- Personal Services
- Real Estate
- REITs
- Restaurants
- Retail - Cyclical
- Retail - Defensive
- Semiconductors
- Software
- Steel
- Telecommunication Services
- Tobacco Products
- Transportation
- Travel & Leisure
- Utilities - Independent Power Producers
- Utilities - Regulated
- Vehicles & Parts
- Waste Management
GuruFocus News Drug Manufacturers Marksans Pharma Ltd (BOM:524404) Q2 FY25 Earnings Call Highlights: Strong Revenue Growth and Strategic Market Expansion
Marksans Pharma Ltd (BOM:524404) reports impressive revenue growth driven by new product launches and market share gains, despite challenges in the UK and Europe. Nov 14, 2024
GuruFocus News Drug Manufacturers Glass House Brands Inc (GLASF) Q3 2024 Earnings Call Highlights: Record Production Growth Amid Market Challenges
Glass House Brands Inc (GLASF) reports significant production increases and operational efficiencies, while navigating pricing pressures and market volatility. Nov 14, 2024
GuruFocus News Drug Manufacturers Aytu BioPharma Inc (AYTU) Q1 2025 Earnings Call Highlights: A Historic Quarter with Positive Net Income and Strategic Growth Initiatives
Aytu BioPharma Inc (AYTU) achieves its first-ever positive net income, while expanding its ADHD and pediatric portfolios amidst revenue challenges. Nov 14, 2024
GuruFocus News Drug Manufacturers Vireo Growth Inc (VREOF) Q3 2024 Earnings Call Highlights: Revenue Growth and Strategic Expansions Amid Operational Challenges
Vireo Growth Inc (VREOF) reports a 6.2% revenue increase, driven by Maryland's market gains, while navigating capacity constraints and regulatory hurdles. Nov 14, 2024
GuruFocus News Drug Manufacturers Durect Corp (DRRX) Q3 2024 Earnings Call Highlights: Revenue Growth Amid Cost Reductions and Strategic Challenges
Durect Corp (DRRX) reports increased revenues and reduced expenses, while navigating funding needs for a pivotal Phase 3 trial. Nov 14, 2024
GuruFocus News Drug Manufacturers Talphera Inc (TLPH) Q3 2024 Earnings Call Highlights: Strategic Advances and Financial Challenges
Talphera Inc (TLPH) reports progress in clinical trials and regulatory pathways, while addressing enrollment hurdles and financial needs. Nov 14, 2024
GuruFocus News Drug Manufacturers Eli Lilly's (LLY) Tirzepatide Shows Sustained Weight and Diabetes Benefits in Phase 3 Study
Nov 14, 2024
GuruFocus News Drug Manufacturers LLY's Zepbound Faces Challenges, While NVO's Wegovy Shines in Weight Loss Market
Nov 14, 2024
GuruFocus News Drug Manufacturers Ayr Wellness Inc (AYRWF) Q3 2024 Earnings Call Highlights: Strategic Expansions Amidst Revenue Challenges
Ayr Wellness Inc (AYRWF) navigates market expansions and cost savings while addressing revenue declines and leadership changes. Nov 14, 2024
GuruFocus News Drug Manufacturers Kamada Ltd (KMDA) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Increased EBITDA Guidance
Kamada Ltd (KMDA) reports a 10% revenue increase and raises full-year EBITDA guidance, despite challenges in clinical trials and market competition. Nov 14, 2024
GuruFocus News Drug Manufacturers PhotoCure ASA (PHCUF) Q3 2024 Earnings Call Highlights: Strong Financial Performance and Strategic Expansions
PhotoCure ASA (PHCUF) reports its sixth consecutive quarter of positive EBITA, with significant growth in Europe and strategic advancements in the US and China. Nov 14, 2024
GuruFocus News Drug Manufacturers Alkem Laboratories Ltd (BOM:539523) Q2 2025 Earnings Call Highlights: Strong Net Profit Growth Amidst US Market Challenges
Alkem Laboratories Ltd (BOM:539523) reports a robust 36% net profit growth in H1 FY25, despite facing significant hurdles in the US market. Nov 14, 2024
GuruFocus News Drug Manufacturers H. Lundbeck AS (HLUBF) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic Brand Performance
H. Lundbeck AS (HLUBF) reports robust financial results with significant growth in strategic brands and a positive outlook for the year. Nov 14, 2024
GuruFocus News Drug Manufacturers SMS Pharmaceuticals Ltd (BOM:532815) Q2 2025 Earnings Call Highlights: Strong Revenue Growth Amidst Margin Pressures
Despite an 18% revenue increase, SMS Pharmaceuticals Ltd faces challenges with declining gross margins due to rising raw material costs and industry pressures. Nov 14, 2024
GuruFocus News Drug Manufacturers Natco Pharma Ltd (BOM:524816) Q2 FY25 Earnings Call Highlights: Robust Revenue and Profit Growth Amid Market Challenges
Natco Pharma Ltd (BOM:524816) reports a 35.3% revenue increase and 83% profit growth, while navigating future market uncertainties and regulatory challenges. Nov 14, 2024
Faizan Farooque Drug Manufacturers Eli Lilly's Tirzepatide Reduces Type 2 Diabetes Risk by 94% in Long-Term Study
Eli Lilly's Phase 3 SURMOUNT-1 study reports that tirzepatide reduced the progression of diabetes Nov 14, 2024
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers